HOME › DRUGS › NECITUMUMAB
ACTIVE SUBSTANCE / INN

NECITUMUMAB

Brand name(s): Portrazza, PORTRAZZA
FDA LISTED
EMA LISTED
PRESCRIPTION
WITHDRAWN
Carcinoma, Non-Small-Cell Lung
BLA125547
ACTIVE SUBSTANCE
Necitumumab
REGULATORS
FDA · EMA
SPONSORS / MAH
ELI LILLY CO, Eli Lilly Nederland B.V.
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
PORTRAZZABLA125547ELI LILLY COPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
PortrazzaEli Lilly Nederland B.V.Withdrawn15/02/2016Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON NECITUMUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →